CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2
Mogamat Razeen Davids, L. B. Tan, Moshe Garty, Giuseppe Conte(University of Campania "Luigi Vanvitelli"), Roberto Minutolo(University of Campania "Luigi Vanvitelli"), Jonathan Beauchamp(Alexion Pharma (Switzerland)), Sinan Uslu(Pamukkale University), Elad Goldberg, Mauro Neri, Vincenzo Bellizzi, Tania Zaglia(Veneto Institute of Molecular Medicine), Véronique Frémeaux‐Bacchi(Assistance Publique – Hôpitaux de Paris), Silvio Borrelli(University of Campania "Luigi Vanvitelli"), Hande Şenol(Pamukkale University), Laurence Greenbaum(Duke University), G. Ardissino, E Cohen, Yu‐Kang Tu(National Taiwan University), Valentina Corradi(University of Calgary), Simin Rota(Pamukkale University), Shanmugakumar Chinnappa, Paolo Chiodini(University of Campania "Luigi Vanvitelli"), A. Brendolan, Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Halil Tanrıverdi(Pamukkale University), Sheridan Johnson(Boston Children's Hospital), Federico Nalesso, Masayo Ogawa(Alexion Pharma (Switzerland)), Francis B. Gabbai(University of California San Diego), Y. Sahan(Pamukkale University), David J. Cohen(St. Francis Hospital), Belda Dursun(Pamukkale University), Fabiana De Martino(Imperial College London), Gema Ariceta, Claudio Ronco(Ospedale San Bortolo), Luca De Nicola(University of Campania "Luigi Vanvitelli"), Christoph Licht(University of Toronto), Maria Teresa Zanella, Elisa Scalzotto, J. Van De Walle(University of Campania "Luigi Vanvitelli"), Franz Schaefer(Heidelberg University), Giovanna Stanzione(University of Campania "Luigi Vanvitelli"), A. Mooney, F. Nappi, A. Meguid El Nahas(Regional Cancer Center, Thiruvananthapuram), J. Jacobs, Nicola Marais, Irit Krause(Children's Medical Center), Marco Mongillo
Cited by 1
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
|Nature Reviews Nephrology|2017|1.5k
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
|European Heart Journal|2021|1.2k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k